-- Jazz Pharma sets IPO at 6 mln shares, $24-$26 each
-- 
-- Thu May 17, 2007 6:18am EDT
-- http://www.reuters.com/article/2007/05/17/us-jazzpharma-ipo-idUSN1726268820070517

 

 WASHINGTON  (Reuters) - Jazz Pharmaceuticals Inc. on Thursday set its planned initial public offering at 6 million shares for an estimated price of $24 to $26 each. 

 The company, which focuses on developing products for neurology and psychiatry medical needs, said in an amended filing with the U.S. Securities and Exchange Commission that Morgan Stanley, Lehman Brothers, Credit Suisse and Natexis Bleichroeder Inc. were underwriting the IPO. The underwriters will have the option to buy an additional 900,000 shares to cover overallotments.